Cargando…
Reply to “Benralizumab as a First-line Treatment for ABPA: Is It Really Indicated?”
Autores principales: | Matsuura, Hiroaki, Fujiwara, Keiichi, Omori, Hiroki, Onishi, Kiriko, Kuribayashi, Tadahiro, Mitsumune, Sho, Takigawa, Yuki, Kudo, Kenichiro, Sato, Akiko, Sato, Ken, Shibayama, Takuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381187/ https://www.ncbi.nlm.nih.gov/pubmed/33583909 http://dx.doi.org/10.2169/internalmedicine.6952-20 |
Ejemplares similares
-
Successful Treatment with Benralizumab for Allergic Bronchopulmonary Aspergillosis That Developed after Disastrous Heavy Rainfall in Western Japan
por: Matsuura, Hiroaki, et al.
Publicado: (2020) -
Optic Perineuritis Associated with Nivolumab Treatment for Non-Small Cell Lung Cancer
por: Takada, Kenji, et al.
Publicado: (2021) -
Thrombotic Microangiopathy Associated with Gemcitabine in Non-Small Cell Lung Cancer: A Case Report
por: Kuribayashi, Tadahiro, et al.
Publicado: (2021) -
Acute eosinophilic pneumonia caused by nicotine‐free vaping in an adolescent patient: A case report
por: Takigawa, Yuki, et al.
Publicado: (2022) -
Lambert-Eaton Myasthenic Syndrome Recurrence Induced by Pembrolizumab in a Patient with Non-small-cell Lung Cancer
por: Takigawa, Yuki, et al.
Publicado: (2022)